yohimbine has been researched along with Clerambault Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, T; Liu, C; Wang, J; Xin, Y; Xu, A | 1 |
| Dietzel, M; Grünberger, J; Lesch, OM; Musalek, M; Saletu, B; Schjerve, M; Walter, H; Werner, U; Zeiler, K | 1 |
2 other study(ies) available for yohimbine and Clerambault Syndrome
| Article | Year |
|---|---|
Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-κB signaling pathway.
Topics: Animals; Dexmedetomidine; Hippocampus; HMGB1 Protein; Neurocognitive Disorders; Neuroinflammatory Diseases; Neuroprotective Agents; NF-kappa B; Rats; Receptor for Advanced Glycation End Products; Receptors, Adrenergic; Signal Transduction; Yohimbine | 2022 |
[Therapy of organic psychosyndromes of cerebrovascular origin with a vasoactive drug combination].
Topics: Adult; Aged; Cerebrovascular Disorders; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Humans; Middle Aged; Neurocognitive Disorders; Psychological Tests; Secologanin Tryptamine Alkaloids; Self-Assessment; Yohimbine | 1985 |